Shijiazhuang Kidney Disease Hospital located in Shijiazhuang city – capital of Hebei Province, which adjoined to Beijing and Tianjin city. Shijiazhuang Kidney Hospital was founded in 1986, and it has developed into a new modernized kidney disease treatment organization.
Basic scale of Shijiazhuang Kidney Disease Hospital
Shijiazhuang Kidney Disease Hospital is the largest special kidney disease hospital with the fullest and best equipment in our country, which was totally programmed according to the specialized hospital standard of class-3, grade-A. Shijiazhuang Kidney Disease Hospital located in No. 5 Feiyi Road Shijiazhuang City, with Water Park nearby. The hospital covers tens of Mus; with building area more than 4000 square metres. Our hospital has the largest scale and richest doctor resource among the kidney disease hospitals all over China.
Shijiazhuang Kidney Disease Research Institute is the subordinate research institute of the Hospital. The Institute mainly works on clinical studies of kidney disease and key tasks of the difficult and baffling diseases, and now doing the research of kidney stem cells of both basic and clinical use. The Institute has published several nephrotic treatment works and hundreds of professional papers. Meanwhile, the Institute is in charge of daily management of “Nephrotic Associated Partners”, edition and issue of hospital periodical.
The In-service Education Center of Shijiazhuang Kidney Disease Hospital is the specialized training institution of the hospital. It mainly provides pre-post education and in-service training for members in and out of our hospital, which is taught by well-known experts of kidney disease. The institution supplied large amount of skilled doctors and clinical experts of kidney disease for the clinic and research, which helps improved the doctors’ clinical treatment level and guaranteed the clinical effect.
Characteristic Medical Treatment of Shijiazhuang Kidney Disease Hospital
Shijiazhuang Kidney Disease Hospital is a now the only specialized hospital with the most detailed branches and most complete administrative departments in the field of kidney disease treatment all over China. According to the types of Nephropathy, the hospital set eighteen inpatient areas, which are Nephritis, Nephrotic Syndrome, Renal Failure, Uremia, Renal Cyst, Diabetes Nephropathy, Hypertension Nephropathy, Renal Purpura, Renal Pediatrics, Renal Rehabilitation Department, etc.
Meanwhile, our hospital is equipped with large-scale hemodialysis center. The 36 sets of dialysis machine and 3 sets of ultrafilter are available to assort and promote several complex dialysis tasks. The 39 sets of dialysis equips and 2 sets of water treatment facilities are all “Fusenyousi” top-grade equipment originally imported from Germany, which provided a reliable guarantee for the clinical treatment.
The item of Renal Fibrosis Inspection of Shijiazhuang Kidney Disease Hospital is the important basis that supports the theory of Renal Fibrosis, in which test of “Matrix Metalloproteinases MMPs” content study, displaying the degree of Renal Fibrosis, is a domestic original project; we took a comparison test between routine examination and test of intrinsic kidney cells injury condition & degree of Renal Fibrosis, which not only provided abundance practical science basis, but also mass of detailed experimental data for the combined traditional Chinese medical treatment and western medical treatment. And this has got high praise from industry colleagues.
The therapy of Blocking Renal Fibrosis by Micro-Chinese Medicine Osmosis is summarized by Shijiazhuang Kidney Disease Hospital as the head characteristic therapy. After years of clinical practice and testing of tens of thousands of cases, now the book ‘Renal Fibrosis Basic Theory and Clinical Practice‘ (published by Hebei Science Press) has already been published and issued. This book recorded our hospital’s pathology and achievements on kidney disease of the past more than twenty years detailed, and became the first monograph in renal fibrosis field in China.
